Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2010
11/04/2010US20100278743 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling
11/04/2010US20100278736 FLT4 (VEGFR-3) as a Target for Tumor Imaging and Anti-Tumor Therapy
11/04/2010US20100278724 Inhibition of migration and induction of cell death by the type ii collagen amino propeptides
11/04/2010US20100275502 Rodenticide
11/04/2010CA2760839A1 Modified compstatin with peptide backbone and c-terminal modifications
11/04/2010CA2760042A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010CA2759424A1 Collagen peptide composition having good ability to enter the blood and food or beverage containing the same
11/04/2010CA2757638A1 Erg monoclonal antibodies
11/04/2010CA2756760A1 Compositions and methods for screening and using compounds antagonizing spore-surface interactions
11/04/2010CA2756442A1 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
11/03/2010EP2246443A1 Antisense modulation of PTP1B expression
11/03/2010EP2246367A1 Low-molecular-weight substance derived from maitake mushroom and having immunostimulating activity and anti-tumor activity
11/03/2010EP2246363A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
11/03/2010EP2246362A2 Polymer conjugates of mutated neublastin
11/03/2010EP2246361A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2010EP2246360A1 Compositions for the treatment of gastrointestinal disorders
11/03/2010EP2246358A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2246357A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2246066A1 Use of neurotoxin therapy for treatment of urologic and related disorders
11/03/2010EP2246065A1 Intrastriatal botulinum toxin therapy
11/03/2010EP2246064A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof
11/03/2010EP2246063A1 Sustained release formulations comprising GnRH analogues
11/03/2010EP2246062A1 Methods and compositions for emergency contraception using endothelin receptor antagonists
11/03/2010EP2245158A2 Impaired wound healing compositions and treatments
11/03/2010EP2245150A1 Protease for wound conditioning and skin care
11/03/2010EP2245149A2 Peptides, compositions, and uses thereof
11/03/2010EP2245145A2 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
11/03/2010EP2245061A2 Impaired wound healing compositions and treatments
11/03/2010EP2245052A2 Selective exosite inhibition of papp-a activity against igfbp-4
11/03/2010EP2245047A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as vehicles for the specific delivery of compounds to the liver
11/03/2010EP2245043A1 A method of purifying a peptide
11/03/2010EP2244814A2 Recombinant vwf formulations
11/03/2010EP2244728A2 Use of serine protease inhibitors in the treatment of skin diseases
11/03/2010EP2244727A1 A method for restoring bmp-receptor signaling in a cell
11/03/2010EP2244726A2 Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) in a selected subpopulation of ich patients
11/03/2010EP2244725A1 Novel peptides and protein and uses thereof
11/03/2010EP2244724A1 Use of peptides for promoting wound healing
11/03/2010EP2244723A2 Compositions and methods for treating diseases associated with angiogenesis and inflammation
11/03/2010EP2244722A1 Treatment of microbial infections
11/03/2010EP2244721A2 Sulfone substituted 2,3-dihydroimidazo ý1,2-c¨quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
11/03/2010EP2244720A2 Polypeptide vaccine and vaccination strategy against mycobacterium
11/03/2010EP2244719A1 Wound healing peptides and methods of use thereof
11/03/2010EP2244718A2 Peptides having binding affinity to an antibody which recognizes an epitope on an 1 loop 2 or 2 loop 1 of an adrenoreceptor
11/03/2010EP2244698A1 Biodegradable therapeutic nanoparticles containing an antimicrobial agent
11/03/2010EP2244694A2 Therapeutic compositions comprising an amine-containing lipid and a protein
11/03/2010EP2244679A1 Non-polymeric compositions for controlled drug delivery
11/03/2010EP1896056B1 Reinforced collagen scaffold
11/03/2010EP1841790B1 Ephb receptor-binding peptides
11/03/2010EP1741792B1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2010EP1702625B1 Medicine containing genetically modified antibody against chemokine receptor ccr4
11/03/2010EP1617858B1 Caspase 3, 8, 9 or 10 inhibitors in combination with MEK inhibitors for the treatment of influenza
11/03/2010EP1599496B1 Hepatitis c inhibitor peptide analogs
11/03/2010EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring
11/03/2010EP1469834B1 Multi-stage oral drug controlled-release system
11/03/2010EP1268760B1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
11/03/2010EP1159457B1 T cell receptor vbeta - dbeta - jbeta) sequence and methods for its detection
11/03/2010EP1076662B1 Polyepitope carrier protein
11/03/2010EP1064019B1 Chemically modified mutant enzymes and methods for producing them and screening them
11/03/2010EP1005376B1 Compositions for use in gene therapy for treatment of hemophilia
11/03/2010EP0912734B1 Chimeric heteromultimer adhesins
11/03/2010EP0719273B1 Nucleotide analogs
11/03/2010EP0568575B2 Test and model for alzheimer's disease
11/03/2010CN1958074B Injectable block copolymer hydrogel of temperature sensibility(epsi - caprolactone - glycolide)- polyethyleneglycol
11/03/2010CN1244215B Improved method for the production and purification of adenoviral vectors
11/03/2010CN101878226A New synthetic arginine substituted peptides and their use
11/03/2010CN101878224A Erythropoietin
11/03/2010CN101878223A Methods of treating cancer using NOTCH pathway inhibitors
11/03/2010CN101878043A PEG-interferon-beta formulations
11/03/2010CN101878037A Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection
11/03/2010CN101878036A A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
11/03/2010CN101878033A Methods of treating or preventing inflammatory diseases of the intestinal tract
11/03/2010CN101877963A Method of delaying the onset of clinically definite multiple sclerosis
11/03/2010CN101877961A Use of neuregulin for organ preservation
11/03/2010CN101875922A Two uricases from baccilus fastidious and mutants thereof as well as polyethylene glycol modification and application thereof
11/03/2010CN101875700A Method for improving bioactivity of exendin fusion protein
11/03/2010CN101875699A Fusion protein of human epidermal growth factor and metallothionein and preparation method and application thereof
11/03/2010CN101875693A Albumin variant having anti-angiogenesis activity and preparation method thereof
11/03/2010CN101875691A Scorpion arialgesic antitumoral peptide mutant and preparation method thereof
11/03/2010CN101875688A Folic acid modification step of method for preparing recombinant tumor specific apoptosis factor and application of products of recombinant tumor specific apoptosis factor
11/03/2010CN101874896A Immune potentiator and recombinant IFN-alpha combined medicament
11/03/2010CN101874895A Application of CART (Cocaine Amphetamine Regulated Transcript) in preparing medicaments for treating alzheimers diseases
11/03/2010CN101874774A Suspension composition containing lysozyme and florfenicol and preparation method thereof
11/03/2010CN101407801B Preparation of earthworm fibrinolytic enzyme from Pheretima guillelmi Michaelsen and lyophilized powder preparation for injection prepared thereby
11/03/2010CN101353688B Preparation and use of kudzu root peptides
11/03/2010CN101287449B Preservation of bioactive materials by spray drying
11/03/2010CN101280004B Polypeptide ERC(N5) for specific inhibition of tumor cell and tumor angiogenic blood vessel
11/03/2010CN101130081B Use of PNAS-4 gene in preparing antineoplastic and antineoplastic auxiliary medicament
11/03/2010CN101095947B Multilevel bionic melissa powder and the method for preparing the same
11/03/2010CN100999553B HR2 analogous protein and its coding gene and application
11/02/2010US7825236 Phosphodiesterase inhibitor for treatment and prevention of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis
11/02/2010US7825228 Bone mineralization proteins, DNA, vectors, expression systems
11/02/2010US7825226 Pharmacokinetics; glycosyltransferases
11/02/2010US7825220 Growth suppressor protein-1 (Gros1) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
11/02/2010US7825217 amino acid sequence including PHEX zinc binding domain and two ASARM binding domains; biodrug for bone disorders, osteoporosis
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825215 Substituted nucleic acid mimics
11/02/2010US7825130 Phosphatase and Tensin homolog deleted on chromosome Ten (PTEN), a tumor suppressor gene or calcium sensitive potassium channel modulators, comprising tetrazolylalkoxy-dihydrocarbostyril compounds such as Cilostazol , used for the treatment of Alzheimer's disease
11/02/2010US7825093 Methods of using OSK1 peptide analogs
11/02/2010US7825092 Dendroaspis natriuretic peptide for treatment of cancer
11/02/2010US7825091 Injection, oral, rectal, nasal, or transdermal delivery of oxyntomodulin and either peptide YY or a peptide YY agonist as prevention or prophylaxis of obesity
1 ... 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 ... 3163